Literature DB >> 11979402

Glucoregulatory endocrine responses to intermittent exercise of different intensities: plasma changes in a pancreatic beta-cell peptide, amylin.

R R Kraemer1, E O Acevedo, L B Synovitz, R J Durand, L G Johnson, E Petrella, M S Fineman, T Gimpel, V D Castracane.   

Abstract

Amylin, a peptide hormone released from the beta cells of the pancreas and cosecreted with insulin, is reported to inhibit the release of postprandial glucagon and insulin and to modulate gastric emptying. Changes in insulin and glucagon are important for controlling blood glucose levels under conditions in which metabolic rate is elevated, such as during and following exercise. Amylin may participate in the regulation of blood glucose levels in response to exercise, although the role of amylin has not been investigated. The purpose of the study was to determine the effects of a progressive, intermittent exercise protocol on amylin concentrations and to compare its response to circulating levels of insulin, glucagon, cortisol, and glucose. Seven well-trained males completed an intermittent exercise trial on a treadmill at four progressive exercise intensities: 60%, 75%, 90%, and 100% of maximum oxygen consumption (.VO(2)max). Blood samples were collected before exercise, after each exercise intensity, and for 1 hour following the exercise protocol. Subjects also completed a control trial with no exercise. Amylin and insulin rose from baseline (5.79 +/-.78 pmol/L and 4.76 +/-.88 microIU/mL) to peak after 100% .VO(2)max (9.16 +/- 1.35 pmol/L and 14.37 +/- microIU/ml), respectively and remained elevated during much of recovery. Thus, a progressive intermittent exercise protocol of moderate to maximum exercise intensities stimulates increases in amylin levels in well-trained individuals in a similar fashion to that of insulin, whereas glucagon concentrations only increase after the greatest exercise intensity, then quickly decline. Future studies should examine the effects of higher amylin concentrations in exercise recovery on glucoregulation. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11979402     DOI: 10.1053/meta.2002.32023

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  9 in total

1.  Effects of high-intensity exercise on leptin and testosterone concentrations in well-trained males.

Authors:  Robert R Kraemer; Robert J Durand; Edmund O Acevedo; Lisa G Johnson; Linda B Synovitz; Ginger R Kraemer; Terry Gimpel; V Daniel Castracane
Journal:  Endocrine       Date:  2003-08       Impact factor: 3.633

Review 2.  Amylin and its G-protein-coupled receptor: A probable pathological process and drug target for Alzheimer's disease.

Authors:  Wei Qiao Qiu
Journal:  Neuroscience       Date:  2017-05-19       Impact factor: 3.590

3.  Effects of prolonged exercise on agouti-related protein: a pilot study.

Authors:  Robert R Kraemer; V Daniel Castracane; Michelle Francois; Abbass Ghanbari-Niaki; Bovorn Sirikul; Roldán A Valverde
Journal:  Endocrine       Date:  2012-04-03       Impact factor: 3.633

4.  Responses of growth hormone aggregates to different intermittent exercise intensities.

Authors:  Martyn R Rubin; William J Kraemer; Robert R Kraemer; Robert J Durand; Edmund O Acevedo; Lisa G Johnson; V D Castracane; Timothy P Scheett; Duncan N French; Jeff S Volek
Journal:  Eur J Appl Physiol       Date:  2003-01-31       Impact factor: 3.078

5.  Ghrelin and other glucoregulatory hormone responses to eccentric and concentric muscle contractions.

Authors:  R R Kraemer; R J Durand; D B Hollander; J L Tryniecki; E P Hebert; V D Castracane
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

6.  No effect of menstrual cycle phase on glucose and glucoregulatory endocrine responses to prolonged exercise.

Authors:  Robert R Kraemer; Michelle Francois; Nancy Dardis Webb; Jennifer R Worley; Sharon N Rogers; Reid L Norman; Urvi Shah; V Daniel Castracane; V Daniel Castracane
Journal:  Eur J Appl Physiol       Date:  2013-06-14       Impact factor: 3.078

7.  Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?

Authors:  Wei Qiao Qiu; Haihao Zhu
Journal:  Front Aging Neurosci       Date:  2014-07-29       Impact factor: 5.750

Review 8.  The molecular signaling of exercise and obesity in the microbiota-gut-brain axis.

Authors:  Filipe M Ribeiro; Maycon A Silva; Victória Lyssa; Gabriel Marques; Henny K Lima; Octavio L Franco; Bernardo Petriz
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-28       Impact factor: 6.055

Review 9.  The endocrine pancreas during exercise in people with and without type 1 diabetes: Beyond the beta-cell.

Authors:  Olivia McCarthy; Signe Schmidt; Merete Bechmann Christensen; Stephen C Bain; Kirsten Nørgaard; Richard Bracken
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-06       Impact factor: 6.055

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.